دورية أكاديمية
Prolyl Oligopeptidase From Leishmania infantum : Biochemical Characterization and Involvement in Macrophage Infection.
العنوان: | Prolyl Oligopeptidase From Leishmania infantum : Biochemical Characterization and Involvement in Macrophage Infection. |
---|---|
المؤلفون: | Lasse C; Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil., Azevedo CS; Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil.; UMR 7245 MCAM, Musèum National d'Histoire Naturelle, Centre National de la Recherche Scientifique, Paris, France., de Araújo CN; Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil.; Faculty of Ceilandia, University of Brasília, Brasília, Brazil., Motta FN; Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil.; Faculty of Ceilandia, University of Brasília, Brasília, Brazil., Andrade MA; Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil.; UMR 7245 MCAM, Musèum National d'Histoire Naturelle, Centre National de la Recherche Scientifique, Paris, France., Rocha AP; Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil., Sampaio I; Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil., Charneau S; Laboratory of Protein Chemistry and Biochemistry, Department of Cell Biology, University of Brasília, Brasília, Brazil., Gèze M; UMR 7245 MCAM, Musèum National d'Histoire Naturelle, Centre National de la Recherche Scientifique, Paris, France.; CeMIM, Musèum National d'Histoire Naturelle, Paris, France., Grellier P; UMR 7245 MCAM, Musèum National d'Histoire Naturelle, Centre National de la Recherche Scientifique, Paris, France., Santana JM; Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil., Bastos IMD; Pathogen-Host Interface Laboratory, Department of Cell Biology, University of Brasília, Brasília, Brazil. |
المصدر: | Frontiers in microbiology [Front Microbiol] 2020 May 28; Vol. 11, pp. 1060. Date of Electronic Publication: 2020 May 28 (Print Publication: 2020). |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101548977 Publication Model: eCollection Cited Medium: Print ISSN: 1664-302X (Print) Linking ISSN: 1664302X NLM ISO Abbreviation: Front Microbiol Subsets: PubMed not MEDLINE |
أسماء مطبوعة: | Original Publication: Lausanne : Frontiers Research Foundation |
مستخلص: | Leishmania infantum is a flagellated protozoan and one of the main causative agents of visceral leishmaniasis. This disease usually affects the human reticuloendothelial system, can cause death and available therapies may lead to serious side effects. Since it is a neglected tropical disease, the incentives for the development of new drugs are insufficient. It is important to know Leishmania virulence factors that contribute most to the disease in order to develop drugs. In the present work, we have produced L. infantum prolyl oligopeptidase (rPOPLi) in Escherichia coli , and investigated its biochemical properties as well as the effect of POP inhibitors on its enzymatic activity and on the inhibition of the macrophage infection by L. infantum . The optimal activity occurred at pH 7.5 and 37°C in the presence of DTT, the latter increased rPOPLi catalytic efficiency 5-fold on the substrate N- Suc-Gly-Pro-Leu-Gly-Pro-AMC. The enzyme was inhibited by TPCK, TLCK and by two POP specific inhibitors, Z-Pro-prolinal (ZPP, IC (Copyright © 2020 Lasse, Azevedo, de Araújo, Motta, Andrade, Rocha, Sampaio, Charneau, Gèze, Grellier, Santana and Bastos.) |
References: | Protein Expr Purif. 2017 Jan;129:101-107. (PMID: 27693621) Front Cell Infect Microbiol. 2012 Jan 09;1:26. (PMID: 22919591) Parasit Vectors. 2018 Jun 19;11(1):355. (PMID: 29921321) Bioorg Med Chem. 2002 Jun;10(6):1719-29. (PMID: 11937331) ChemMedChem. 2007 Mar;2(3):354-9. (PMID: 17295371) Int J Pept Protein Res. 1993 Feb;41(2):147-52. (PMID: 8458688) Biochem J. 1990 Oct 15;271(2):559-62. (PMID: 2241932) Drug News Perspect. 2007 Jun;20(5):293-305. (PMID: 17878957) Curr Med Chem. 2013;20(25):3103-15. (PMID: 23514419) Microbes Infect. 2010 Jun;12(6):457-66. (PMID: 20188209) Parasitol Res. 1992;78(7):553-6. (PMID: 1438145) J Biol Chem. 2001 Dec 14;276(50):47078-86. (PMID: 11598112) Bioorg Med Chem Lett. 1999 Feb 8;9(3):437-42. (PMID: 10091698) Mol Biochem Parasitol. 1988 Jan 1;27(1):43-52. (PMID: 3278222) Am J Physiol Renal Physiol. 2016 May 15;310(10):F1026-34. (PMID: 26962108) Biochimie. 2010 Oct;92(10):1274-86. (PMID: 20595064) BMC Complement Altern Med. 2016 Nov 8;16(1):444. (PMID: 27825341) Biochem J. 1997 Jul 1;325 ( Pt 1):129-37. (PMID: 9224638) J Biol Chem. 2011 Jan 7;286(1):429-40. (PMID: 20961853) PLoS Negl Trop Dis. 2018 Mar 30;12(3):e0006384. (PMID: 29601585) J Investig Dermatol Symp Proc. 2001 Dec;6(3):175-82. (PMID: 11924824) J Comput Aided Mol Des. 2016 Dec;30(12):1165-1174. (PMID: 27770305) Front Immunol. 2019 Mar 21;10:544. (PMID: 30949181) Immunol Rev. 2015 Nov;268(1):311-27. (PMID: 26497530) PLoS Negl Trop Dis. 2015 Jun 03;9(6):e0003827. (PMID: 26039195) J Proteome Res. 2015 Feb 6;14(2):1033-59. (PMID: 25536015) FEBS Lett. 1992 Mar 30;300(2):127-30. (PMID: 1563512) Parasitol Res. 2019 Oct;118(10):2743-2752. (PMID: 31473855) Br J Pharmacol. 2011 Aug;163(8):1666-78. (PMID: 21133893) Biochem J. 2006 Mar 15;394(Pt 3):635-45. (PMID: 16248854) Front Microbiol. 2017 Feb 07;8:155. (PMID: 28223969) J Vis Exp. 2013 Nov 22;(81):e50966. (PMID: 24300014) Biochem Pharmacol. 2019 Mar;161:113-120. (PMID: 30660495) Nat Methods. 2012 Jun 28;9(7):676-82. (PMID: 22743772) Biochem J. 2004 Sep 15;382(Pt 3):1003-8. (PMID: 15217351) PLoS Negl Trop Dis. 2017 Jan 3;11(1):e0005281. (PMID: 28045892) Expert Opin Ther Pat. 2011 Jul;21(7):1023-44. (PMID: 21539473) J Extracell Vesicles. 2018 Nov 08;8(1):1541708. (PMID: 30455859) Neuroreport. 2001 Oct 29;12(15):3309-12. (PMID: 11711876) Microbiol Mol Biol Rev. 1998 Sep;62(3):597-635. (PMID: 9729602) Rev Soc Bras Med Trop. 2016 Sep-Oct;49(5):593-601. (PMID: 27812654) Eur J Med Chem. 2000 Feb;35(2):257-66. (PMID: 10758287) Bioorg Med Chem Lett. 2003 Sep 1;13(17):2875-8. (PMID: 14611847) PLoS One. 2011;6(11):e26251. (PMID: 22132071) Biochim Biophys Acta. 2013 Jan;1834(1):98-111. (PMID: 22940581) J Cell Sci. 1989 Jul;93 ( Pt 3):491-500. (PMID: 2606940) PLoS Pathog. 2009 Jun;5(6):e1000464. (PMID: 19503602) Biochem J. 2005 May 15;388(Pt 1):29-38. (PMID: 15581422) Chem Sci. 2015 May 1;6(5):2650-2659. (PMID: 28706662) Cell. 1998 Jul 24;94(2):161-70. (PMID: 9695945) J Biochem. 1987 Jun;101(6):1413-27. (PMID: 3667557) Bull Soc Pathol Exot Filiales. 1988;81(3 Pt 2):468-76. (PMID: 3197243) Int J Biochem Cell Biol. 1998 Jan;30(1):99-114. (PMID: 9597757) Cell. 2019 Jan 10;176(1-2):306-317.e16. (PMID: 30503212) Parasitol Res. 2011 Jan;108(1):233-9. (PMID: 20922428) Nucleic Acids Res. 2018 Jan 4;46(D1):D624-D632. (PMID: 29145643) Chem Pharm Bull (Tokyo). 1999 Feb;47(2):194-8. (PMID: 10071854) Biochem Biophys Res Commun. 2018 Jan 15;495(3):2235-2241. (PMID: 29273505) |
فهرسة مساهمة: | Keywords: POPLi; drug target; leishmaniasis; protease; virulence factor |
تواريخ الأحداث: | Date Created: 20200618 Latest Revision: 20200928 |
رمز التحديث: | 20231215 |
مُعرف محوري في PubMed: | PMC7271538 |
DOI: | 10.3389/fmicb.2020.01060 |
PMID: | 32547514 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1664-302X |
---|---|
DOI: | 10.3389/fmicb.2020.01060 |